Session II: Technical Aspects of Bioassays throughout the Product Lifecycle

Session Chair(s):

• Jill Crouse-Zeineddini, Amgen Inc.
• Marina Feschenko, Biogen
• Stephen Hartman, AbbVie Inc.

Session Speaker(s):

• Kristin Abrams, Amgen Inc.
• Ruojia Li, Bristol-Myers Squibb Company
• Madhu Pandey, AstraZeneca
• Martijn van der Plas, MEB-Medical Evaluations Board